Clinical Trial Update: Randomized Trial of SGLT2i in Heart Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating an SGLT2 inhibitor in heart transplant recipients is currently recruiting. The study targets cardiovascular and kidney-relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: VA Office of Research and Development | Conditions: Heart Transplant, Cardiovascular Disease | Phase 4 | Status: RECRUITING